Chemikas Speciality LLP has submitted a disclosure regarding the encumbrance of shares by its promoter. The filing details the creation of a pledge for 8,50,000 shares on June 30, 2026, serving as collateral for loans. Subsequently, 22,00,000 shares were released from pledge on July 3, 2026, following the repayment of availed loans. These actions are in compliance with SEBI regulations, providing transparency on promoter holdings and associated financial arrangements.
Disclosure of Promoter Share Encumbrance
Chemikas Speciality LLP has officially submitted a disclosure regarding the encumbrance and subsequent release of shares held by its promoter. This announcement is made in accordance with Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, ensuring transparency in promoter activities affecting shareholding.
Key Events and Dates
The disclosure highlights two significant events. Firstly, a creation of pledge involving 8,50,000 shares occurred on June 30, 2026. These shares were pledged as collateral for loans, representing 0.69% of the company’s capital. The entity in whose favour this pledge was made is CTL Trusteeship Limited. This initial encumbrance constituted 2.26% of Chemikas Speciality LLP’s capital held by the promoter.
Secondly, a release of pledge took place on July 3, 2026. A total of 22,00,000 shares were released from encumbrance following the successful repayment of the loan that was availed. This release represented 1.78% of the company’s capital. The shares were released from the favour of HDFC Bank Limited, with the post-event holding of encumbered shares by the promoter now standing at 11.3%.
Promoter Details
The promoter entity is Chemikas Speciality LLP. The total promoter holding in Archean Chemical Industries Limited is 3,76,93,219 shares, representing 30.53% of the total shares. Prior to the recent transactions, 1,53,05,210 shares (12.40%) were already encumbered. Following the creation and release of pledge, the net encumbered shares are detailed in Annexure I, which is attached with this disclosure.
Source: BSE
